Sonoma Biotherapeutics

Seattle, United States · Founded 2019 · $410.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$410.0M
Last Round
$75.0M Corporate RoundSep 2024
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat autoimmune and inflammatory diseases by restoring balance to the immune system. Founded by pioneers in Treg biology and cell therapy, the company uses proprietary platform technologies to engineer targeted, durable Treg cell therapies. Its lead program targets rheumatoid arthritis, with additional indications in development through a collaboration with Regeneron.

Summary

Sonoma Biotherapeutics is a Biotech company based in Seattle, United States, founded in 2019. It has raised $410.0M in total across 7 rounds, most recently a $75.0M Corporate Round in Sep 2024. Investors include Regeneron Pharmaceuticals, GV and ARCH Venture Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundRegeneron InvestmentSep 2024
$75.0M

Sign up to see all 7 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sonoma Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/sonoma-biotherapeutics"><img src="https://indexed.vc/api/badge/company/sonoma-biotherapeutics" alt="Sonoma Biotherapeutics on Indexed.vc" width="260" height="76" /></a>